Funding · Company
Cardurion Pharmaceuticals, Inc.
Burlington, MABiotech & Pharma
Cardurion Pharmaceuticals, Inc. of Burlington, MA has disclosed $389M across 2 Form D offerings filed with the SEC between Jul 14, 2023 and Jul 24, 2024.
$389M
Total disclosed
2
Form D offerings
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$128M
Form D · Jul 14, 2023 ↗
Q3 2023
· 1 amendment, first filed Nov 3, 2021
Filing details
HeadquartersBurlington, MAIndustryBiotech & Pharma (Biotechnology)SEC CIK0001702453Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. Spot an error? Full methodology →